How Regulatory Bodies Define Amendment Categories
How Regulatory Bodies Define Amendment Categories How Regulatory Bodies Classify Clinical Trial Protocol Amendments Why Amendment Classification Matters in Clinical Trials Classifying protocol amendments correctly is essential to maintain regulatory compliance and ensure subject safety in clinical trials. Misclassification can lead to delays, inspection findings, and data validity concerns. Regulatory bodies such as the FDA,…
Read More “How Regulatory Bodies Define Amendment Categories” »